ch.oddb.org 
   
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Drugs alphabetical "e", total number of products: 481
Reg.‑No.  ProductComposition 
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
1 - 100101 - 200201 - 300301 - 400401 - 481
54275IPCIExelon 1,5 mgCapsules: Rivastigminum 1.5 mgG
55051IPCIExelon 2 mg/mlSolution (oral): Rivastigminum 2 mg/mlG
54275IPCIExelon 3 mgCapsules: Rivastigminum 3 mgG
54275IPCIExelon 4,5 mgCapsules: Rivastigminum 4.5 mgG
54275IPCIExelon 6 mgCapsules: Rivastigminum 6 mgG
58078IPCIExelon Patch 10Transdermal patch: Rivastigminum 18 mgG
58078IPCIExelon Patch 15Transdermal patch: Rivastigminum 27 mgG
58078IPCIExelon Patch 5Transdermal patch: Rivastigminum 9 mgG
65909IPCIExemestan Devatis 25 mgCoated tablets: Exemestanum 25 mgG
61522IPCIExemestan Sandoz 25Coated tablets: Exemestanum 25 mgG
61523IPCIExemestan ViatrisCoated tablets: Exemestanum 25 mgG
57771IPCIExforge 10/160 mgCoated tablets: 2 Active AgentsG
57771IPCIExforge 5/160 mgCoated tablets: 2 Active AgentsG
57771IPCIExforge 5/80 mgCoated tablets: 2 Active AgentsG
59407IPCIExforge HCT 10 mg/160 mg/12.5 mgCoated tablets: 3 Active AgentsG
59407IPCIExforge HCT 10 mg/160 mg/25 mgCoated tablets: 3 Active AgentsG
59407IPCIExforge HCT 5 mg/160 mg/12.5 mgCoated tablets: 3 Active AgentsG
59407IPCIExforge HCT 5 mg/160 mg/25 mgCoated tablets: 3 Active AgentsG
57466IPCIExjade 125 mgDispersible Tablets: Deferasiroxum 125 mgG
57466IPCIExjade 250 mgDispersible Tablets: Deferasiroxum 250 mgG
57466IPCIExjade 500 mgDispersible Tablets: Deferasiroxum 500 mgG
52137 CIExmykehl D3Suppositories: 3 Active AgentsG
54127 CIExmykehl D5Injection solution: 3 Active AgentsG
54132 CIExmykehl D5Drops: 3 Active AgentsG
53631IP ExtranealPeritoneal dialysis solution: 6 Active AgentsG
62393IP Eylea 2 mg/0.05 mlLösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µlG
62397IP Eylea 8 mg/0.07 mlInjection solution: Afliberceptum 8mg / 0.07mlG
62393IP Eylea 8 mg/0.07mlInjection solution in prefilled syringe: Afliberceptum 8mg / 0.07mlG
62397IP Eylea, 2 mg/0,05 mlInjection solution: Afliberceptum 2mg / 0.05mlG
68284IPCIEzetimib Atorvastatin Sandoz 10 mg / 10 mgFilmtablette: 2 Active AgentsG
68284IP Ezetimib Atorvastatin Sandoz 10 mg / 20 mgFilmtablette: 2 Active AgentsG
68284IP Ezetimib Atorvastatin Sandoz 10 mg / 40 mgFilmtablette: 2 Active AgentsG
68284IP Ezetimib Atorvastatin Sandoz 10 mg / 80 mgFilmtablette: 2 Active AgentsG
68105IPCIEzetimib Atorvastatin Spirig HC 10 mg / 10 mgTablets: 2 Active AgentsG
68105IP Ezetimib Atorvastatin Spirig HC 10 mg / 20 mgTablets: 2 Active AgentsG
68105IP Ezetimib Atorvastatin Spirig HC 10 mg / 40 mgTablets: 2 Active AgentsG
68105IP Ezetimib Atorvastatin Spirig HC 10 mg / 80 mgTablets: 2 Active AgentsG
67060IPCIEzetimib axapharm 10 mgTablets: Ezetimibum 10 mgG
69004IPCIEzetimib Rosuvastatin axapharm 10 mg/10 mgCoated tablets: 2 Active AgentsG
69004IP Ezetimib Rosuvastatin axapharm 10 mg/20 mgCoated tablets: 2 Active AgentsG
68692IP Ezetimib Rosuvastatin Sandoz 10 mg / 10 mgCoated tablets: 2 Active AgentsG
68692IP Ezetimib Rosuvastatin Sandoz 10 mg / 20 mgCoated tablets: 2 Active AgentsG
68692IPCIEzetimib Rosuvastatin Sandoz 10 mg / 5 mgCoated tablets: 2 Active AgentsG
68069IPCIEzetimib Rosuvastatin Spirig HC 10 mg / 10 mgCoated tablets: 2 Active AgentsG
68069IP Ezetimib Rosuvastatin Spirig HC 10 mg / 20 mgCoated tablets: 2 Active AgentsG
68069IP Ezetimib Rosuvastatin Spirig HC 10 mg / 5 mgCoated tablets: 2 Active AgentsG
68526IPCIEzetimib Rosuvastatin Zentiva 10 mg / 10 mgCoated tablets: 2 Active AgentsG
68526IP Ezetimib Rosuvastatin Zentiva 10 mg / 20 mgCoated tablets: 2 Active AgentsG
65100IPCIEzetimib Sandoz 10 mgTablets: Ezetimibum 10 mgG
66233IPCIEzetimib Simva Spirig HC 10/10 mgTablets: 2 Active AgentsG
66233IP Ezetimib Simva Spirig HC 10/20 mgTablets: 2 Active AgentsG
66233IP Ezetimib Simva Spirig HC 10/40 mgTablets: 2 Active AgentsG
66233IP Ezetimib Simva Spirig HC 10/80mg Tabletten: 2 Active AgentsG
66234IPCIEzetimib Simvastatin Sandoz 10/10 mgTablets: 2 Active AgentsG
66234IP Ezetimib Simvastatin Sandoz 10/20 mgTablets: 2 Active AgentsG
66234IP Ezetimib Simvastatin Sandoz 10/40 mgTablets: 2 Active AgentsG
66234IP Ezetimib Simvastatin Sandoz 10/80 mgTablets: 2 Active AgentsG
67242IPCIEzetimib Simvastatin Zentiva 10/10 mgTablets: 2 Active AgentsG
67242IP Ezetimib Simvastatin Zentiva 10/20 mgTablets: 2 Active AgentsG
67242IP Ezetimib Simvastatin Zentiva 10/40 mgTablets: 2 Active AgentsG
67242IP Ezetimib Simvastatin Zentiva 10/80 mgTablets: 2 Active AgentsG
66003IPCIEzetimib Spirig HCTablets: Ezetimibum 10 mgG
66068IPCIEzetimib Zentiva 10mgTablets: Ezetimibum 10 mgG
68282IPCIEzetimib-Atorvastatin-Mepha 10/10 mgCoated tablets: 2 Active AgentsG
68282IP Ezetimib-Atorvastatin-Mepha 10/20 mgCoated tablets: 2 Active AgentsG
68282IP Ezetimib-Atorvastatin-Mepha 10/40 mgCoated tablets: 2 Active AgentsG
68282IP Ezetimib-Atorvastatin-Mepha 10/80 mgCoated tablets: 2 Active AgentsG
65892IPCIEzetimib-Mepha Teva 10 mgTablets: Ezetimibum 10 mgG
67276IPCIEzetimib-Rosuvastatin Viatris 10 mg / 10 mgCoated tablets: 2 Active AgentsG
67276IP Ezetimib-Rosuvastatin Viatris 10 mg / 20 mgCoated tablets: 2 Active AgentsG
68437IP Ezetimib-Rosuvastatin-Mepha 10 mg / 10 mgCoated tablets: 2 Active AgentsG
68437IP Ezetimib-Rosuvastatin-Mepha 10 mg / 20 mgCoated tablets: 2 Active AgentsG
68437IPCIEzetimib-Rosuvastatin-Mepha 10 mg / 5 mgCoated tablets: 2 Active AgentsG
66835IPCIEzetimib-Rosuvastatin-Mepha 10 mg/10 mgCapsules: 2 Active AgentsG
66835IP Ezetimib-Rosuvastatin-Mepha 10 mg/20 mgCapsules: 2 Active AgentsG
67074IPCIEzetimib-Simvastatin-Mepha Teva 10/10 mgTablets: 2 Active AgentsG
67074IP Ezetimib-Simvastatin-Mepha Teva 10/20 mgTablets: 2 Active AgentsG
67074IP Ezetimib-Simvastatin-Mepha Teva 10/40 mgTablets: 2 Active AgentsG
67074IP Ezetimib-Simvastatin-Mepha Teva 10/80 mgTablets: 2 Active AgentsG
66551IPCIEzetimibe Organon 10 mgTablets: Ezetimibum 10 mgG
56195IPCIEzetrolTablets: Ezetimibum 10 mgG
 show caption
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home